Hepatocellular carcinoma (HCC) is a highly lethal cancer, with increasing worldwide
incidence, that is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C …

With an estimate of 350 million people chronically infected with the hepatitis B virus (HBV)
worldwide, it is critically important to understand how persistent HBV infection is maintained …

Intrahepatic hypoxia may occur during the inflammatory and fibrotic processes that
characterize several chronic liver diseases of viral and autoimmune origin. As a …

Wnt/β‐catenin signaling contributes to diverse cellular functions, such as Drosophila wing
development and colon carcinogenesis. Recently, stabilizing mutations of β‐catenin, a …

Chronic hepatitis B virus (HBV) infection remains the number one risk factor for
hepatocellular carcinoma (HCC), accounting for more than 600 000 deaths/year. Despite …

Despite the existence of effective vaccines, HBV infection remains a major health problem
with 2 billion people infected worldwide. Among them, 350 million are chronically infected, a …

Hepatocellular carcinoma is strongly associated with chronic infection by the hepatitis B
virus (HBV) and has poor prognosis due to intrahepatic metastasis. HBx is often the only …

E-cadherin is a key cell adhesion molecule implicated as a tumor suppressor, which is
frequently altered in hepatocellular carcinoma, especially in hepatitis B virus (HBV)-related …

Hepatitis B virus (HBV) is a major aetiology associated with the development and
progression of hepatocellular carcinoma (HCC), the most common primary liver malignancy …

Expression level of metastasis-associated protein 1 (MTA1) is closely related to tumor
growth and metastasis in various cancers. Although increased expression level of MTA1 …